Atlas Trials

Squamous Cell Carcinoma of the Head and Neck (SCCHN)

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Squamous Cell Carcinoma of the Head and Neck (SCCHN)

RecordFirmDate
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies (NCT06974734)Pfizer2025-05-06
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC (NCT05057247)Glenn J. Hanna2021-10-14
Study of INCA 0186 in Subjects With Advanced Solid Tumors (NCT04989387)Incyte Corporation2021-10-04
Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors (NCT04052204)Pfizer2019-12-30
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer (NCT03405142)Eben Rosenthal2019-08-01
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies (NCT03538028)Incyte Biosciences International Sàrl2018-06-18
Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer (NCT02499120)Pfizer2015-09-10
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors (NCT02335918)Celldex Therapeutics2015-01-01
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02001623)Seagen Inc.2013-11-30
Study of PX-866 and Docetaxel in Solid Tumors (NCT01204099)Cascadian Therapeutics Inc.2010-09-01
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck (NCT01285635)University of Michigan Rogel Cancer Center2010-06-01
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck (NCT00392665)Massachusetts General Hospital2006-10-01

Track Squamous Cell Carcinoma of the Head and Neck (SCCHN) automatically

Every clearance here is in the API, with alerts when new ones post.